# Evaluation of Tonabersat for DME

> **NCT05727891** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Jaeb Center for Health Research** · enrollment: 128 (estimated)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Tonabersat
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05727891
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-02
- **Primary completion:** 2025-06-27
- **Final completion:** 2026-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727891, "Evaluation of Tonabersat for DME". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05727891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*